Impact of SARS-CoV-2 Variant NSP6 on Pathogenicity: Genetic Analysis and Cell Biology

Impact of SARS-CoV-2 Variant NSP6 on Pathogenicity: Genetic Analysis and Cell Biology

SARS-CoV-2 nonstructural protein (NSP) 6 is one of the factors affecting viral pathogenicity. Mutations in NSP6 continuously emerge during viral transmission and are closely associated with alterations in viral pathogenicity. This study investigated the structural and functional impacts of NSP6 muta...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yangye Gao, Peng Ni, Yanqiao Hua, Shuaiyin Chen, Rongguang Zhang
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Current Issues in Molecular Biology
Subjects:	SARS-CoV-2 nonstructural protein 6 gene mutation bioinformatics transcriptomics cell signaling pathway
Online Access:	https://www.mdpi.com/1467-3045/47/5/361
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Functional and Evolutionary Characterization of the NSP6 Protein in SARS-CoV-2 Omicron Variants
by: Joyhare Barbosa Souza, et al.
Published: (2025-04-01)

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
by: Chun-Kit Yuen, et al.
Published: (2020-01-01)

Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
by: Cody J. Bills, et al.
Published: (2023-12-01)

Unraveling metabolic signatures in SARS-CoV-2 variant infections using multiomics analysis
by: Sunho Lee, et al.
Published: (2024-12-01)

The Effects of SARS CoV-2 nsp13 Mutations on the Structure and Stability of Helicase in Chinese Isolates
by: Ekrem Akbulut
Published: (2022-06-01)

Genomic surveillance of SARS-CoV-2 variants using pooled WGS
by: Inho Park, et al.
Published: (2025-04-01)

Emergence of Novel SARS-CoV-2 variants in India: second wave
by: Rama Adiga, et al.
Published: (2021-11-01)

A conserved motif within the NSP2 of SARS-CoV-2 is required for processing of the distal NSP1/NSP2 junction by NSP3
by: Thea Kristensen, et al.
Published: (2025-07-01)

SARS-CoV-2 Variants Screening in Burkina Faso
by: Serge Théophile Soubeiga1*, et al.
Published: (2022-09-01)

Omicron Variant Could Be an Antigenic Shift of SARS-CoV-2
by: Anju Kaushal
Published: (2025-05-01)

In-silico Immunomodelling of SARS-CoV-2
by: Amirhosein Maali, et al.
Published: (2021-06-01)

RADx Variant Task Force Program for Assessing the Impact of Variants on SARS-CoV-2 Molecular and Antigen Tests
by: Richard Creager, et al.
Published: (2021-01-01)

Phylogeography and genomic analysis of SARS-CoV-2 delta variant in Morocco
by: Safae El Mazouri, et al.
Published: (2022-08-01)

Differentially expressed ncRNAs as key regulators in infection of human bronchial epithelial cells by the SARS-CoV-2 Delta variant
by: Glory Ranches, et al.
Published: (2025-06-01)

High diversity in Delta variant across countries revealed by genome‐wide analysis of SARS‐CoV‐2 beyond the Spike protein
by: Rohit Suratekar, et al.
Published: (2022-02-01)

Effects of Rotavirus NSP4 on the Immune Response and Protection of Rotavirus-Norovirus Recombinant Subunit Vaccines in Different Immune Pathways
by: Jingping Hu, et al.
Published: (2024-09-01)

A bioinformatics approach combined with experimental validation analyzes the efficacy of azithromycin in treating SARS-CoV-2 infection in patients with IPF and COPD
by: Yining Xie, et al.
Published: (2025-03-01)

Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal
by: Vítor Borges, et al.
Published: (2020-01-01)

Integrating immune library probing with structure-based computational design to develop potent neutralizing nanobodies against emerging SARS-CoV-2 variants
by: Lidia Cerdán, et al.
Published: (2025-12-01)

SARS-CoV-2 Mutations and Their Impacts on Virulence and Transmissibility of The Virus
by: Sajjad Bahman, et al.
Published: (2024-07-01)

Molecular Epidemiology of SARS-CoV-2 in Bangladesh
by: Abu Sayeed Mohammad Mahmud, et al.
Published: (2025-04-01)

Genome Analysis of SARS-CoV-2 Delta variant in the Kurdistan region of Iraq
by: Sevan O Majed, et al.
Published: (2024-11-01)

Host-dependent editing of SARS-CoV-2 in COVID-19 patients
by: Josep Gregori, et al.
Published: (2021-01-01)

Evolution of Antiviral Drug Resistance in SARS-CoV-2
by: Roy Dinata, et al.
Published: (2025-05-01)

New biothreat of JN.1 variant SARS CoV-2: viral genome, mutations and comparison with Delta and Omicron variants – a brief commentary
by: S. Kannan, et al.
Published: (2024-03-01)

Is SARS-CoV-2 facing constraints in its adaptive evolution?
by: Yingguang Liu
Published: (2025-06-01)

Characterization of private mutations in the spike protein of SARS-CoV-2 correlates with viral prevalence
by: Shuo Wang, et al.
Published: (2025-08-01)

SARS-COV-2 causes significant abnormalities in the fibrinolysis system of patients: correlation between viral mutations, variants and thrombosis
by: Esra’a Abudouleh, et al.
Published: (2025-04-01)

N-alkyl and N-benzyl indoles are anti-SARS-CoV-2 agents and nsp13 inhibitors
by: Aurora Albano, et al.
Published: (2025-08-01)

Mosaic vaccine design targeting mutational spike protein of SARS- CoV-2: An immunoinformatics approach
by: Ysrafil Ysrafil, et al.
Published: (2024-04-01)

Engineered ACE2 decoy in dry powder form for inhalation: A novel therapy for SARS-CoV-2 variants
by: Takaaki Ito, et al.
Published: (2025-06-01)

An overview of SARS-COV-2: Virology, Epidemiology, Pathogenesis and Treatment
by: Ramesh Bhandari, et al.
Published: (2020-06-01)

Secondary structure of the SARS-CoV-2 genome is predictive of nucleotide substitution frequency
by: Zach Hensel
Published: (2025-02-01)

Assay development and screening of inhibitors targeting the SARS-CoV-2 2′-O-methyltransferase NSP16
by: Mengtong Cao, et al.
Published: (2025-12-01)

“Outlaw” mutations in quasispecies of SARS-CoV-2 inhibit replication
by: Philippe Colson, et al.
Published: (2024-12-01)

Development and Optimization of SARS-CoV-2-Specific Primers for Accurate Diagnosis: A Case Study in West Sumatra - Indonesia
by: Ony Nattasha Aulia, et al.
Published: (2024-12-01)

The Characteristics of the Delta Variant of SARS-CoV-2 Virus – the Dominant Agent of the Third and Forth Waves of Epidemic COVID-19 in Russia
by: T. E. Sizikova, et al.
Published: (2023-06-01)

Structural and functional analyses of SARS-CoV-2 Nsp3 and its specific interactions with the 5’ UTR of the viral genome
by: Sofia Lemak, et al.
Published: (2025-08-01)

Pulling Forces Differentially Affect Refolding Pathways Due to Entangled Misfolded States in SARS-CoV-1 and SARS-CoV-2 Receptor Binding Domain
by: Pham Dang Lan, et al.
Published: (2024-10-01)

SARS‐CoV‐2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms
by: Seán I O’Donoghue, et al.
Published: (2021-09-01)